Study Overview: This research is looking at how safe and effective an investigational medication is for adults with a type of multiple sclerosis (MS) called nonrelapsing secondary progressive MS (nrSPMS). MS is a disease where the immune system attacks the protective covering of nerves. This can cause problems with movement and vision.
Who Can Join? Adults aged 18 to 60 with a past diagnosis of relapsing-remitting MS (RRMS) and current diagnosis of secondary progressive MS (SPMS) can join if they've shown disability progression in the last year and haven't had relapses for 2 years. They must have a specific disability score and use birth control if required by local rules.
Study Details:
- Duration: The study lasts between 27 to 51 months.
- Visits: Up to 27 visits are needed, starting monthly, then every 3 months.
- Note: Participants cannot have certain other diseases, infections, or allergies, and must not have used the investigational medication before.
Consider joining if you meet the criteria and wish to contribute to MS research.